Literature DB >> 1340864

Benzathine penicillin G for rheumatic fever prophylaxis: 2-weekly versus 4-weekly regimens.

A S Kassem1, A A Madkour, B Z Massoud, S R Zaher.   

Abstract

Rheumatic fever is still one of the major public health problems in Egypt and the developing countries. It is characterized by a high tendency to recur following streptococcal infections. The use of long acting penicillin for prophylaxis against strep infections was a good achievement in this field, yet, recurrences have been reported in patients following monthly prophylactic programs. Clinical experience in Alexandria have shown for a long time that giving penicillin every 2 weeks is followed by less recurrences of rheumatic fever. Recently, reports came showing that effective penicillin levels are not maintained except for 2 to 3 weeks after the injection. In the present study, we compared two regimens of prophylaxis with 190 patients in the 2-weekly regimen, and 170 patients in the 4-weekly regimen being followed up for 2 consecutive years. Two hundred and sixty nine streptococcal infections occurred during this period. Although the streptococcal infection rate was equal in both groups, the rheumatic fever recurrence rate and the RF attack rate were significantly higher in the group of patients on the 4-weekly schedule. The results of this study have shown the superiority of the 2-weekly schedule in the adequate control of RF recurrences. We suggest that this schedule should be implemented for secondary prophylaxis of rheumatic fever in Egypt and other areas with severe RF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1340864     DOI: 10.1007/bf02859412

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  27 in total

1.  Prophylaxis in patients with rheumatic fever: every three or every four weeks?

Authors:  E M Ayoub
Journal:  J Pediatr       Date:  1989-07       Impact factor: 4.406

2.  Serial serum penicillin levels following an injection of benzathine penicillin (12 lakh units) in children of rheumatic heart disease.

Authors:  R K Saran; N Sinha; R C Ahuja; A Mehrotra; S K Jain; M C Bhatia; M Hasan
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

3.  Jones criteria (revised) for guidance in the diagnosis of rheumatic fever.

Authors: 
Journal:  Circulation       Date:  1965-10       Impact factor: 29.690

4.  The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project.

Authors:  T Strasser; N Dondog; A El Kholy; R Gharagozloo; V V Kalbian; O Ogunbi; S Padmavati; K Stuart; E Dowd; A Bekessy
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

5.  Community control of rheumatic heart disease in developing countries: 1 a major public health problem.

Authors: 
Journal:  WHO Chron       Date:  1980-09

6.  Rheumatic fever and rheumatic heart disease in developing countries.

Authors:  S Padmavati
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

7.  Resurgence of acute rheumatic fever.

Authors:  D M Hosier; J M Craenen; D W Teske; J J Wheller
Journal:  Am J Dis Child       Date:  1987-07

8.  Why patients don't follow medical advice: a study of children on long-term antistreptococcal prophylaxis.

Authors:  L Gordis; M Markowitz; A M Lilienfeld
Journal:  J Pediatr       Date:  1969-12       Impact factor: 4.406

9.  Prevention of rheumatic fever. A statement prepared by the Rheumatic Fever Committee of the Council on Rheumatic Fever and Congenital Heart Disease of the American Heart Association.

Authors: 
Journal:  Circulation       Date:  1971-06       Impact factor: 29.690

10.  Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study.

Authors:  S K Sanyal; A M Berry; S Duggal; V Hooja; S Ghosh
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

View more
  4 in total

1.  Prophylactic efficiency of 3-weekly benzathine penicillin G in rheumatic fever.

Authors:  B Oran; A Tastekin; S Karaaslan; L Bas; A Ayçiçek; A Ceri; A Sütçü; I Erkul
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

2.  Reversibility of mitral regurgitation following rheumatic fever: clinical profile and echocardiographic evaluation.

Authors:  A S Kassem; T M el-Walili; S R Zaher; M Ayman
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Antistreptolysin O titer in health and disease: levels and significance.

Authors:  Alyaa Amal Kotby; Nevin Mamdouh Habeeb; Sahar Ezz El Elarab
Journal:  Pediatr Rep       Date:  2012-02-09

4.  Study of the relation between serum levels of long-acting penicillin and the inflammatory markers: C-reactive protein and interleukin-6 in patients with chronic rheumatic heart disease.

Authors:  Ahmad M Yousef; Osama A Rifaie; Mohamed A Hamza; Sameh A Amin
Journal:  Egypt Heart J       Date:  2021-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.